Salesforce (NYSE:CRM – Get Free Report) had its price objective boosted by research analysts at UBS Group from $185.00 to $210.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “neutral” rating on the CRM provider’s stock. UBS Group’s target price would indicate a potential upside of 7.29% from…
